Core Insights - Coherent Corp. has announced a breakthrough in short-reach optical interconnect technology with the demonstration of next-generation 2D VCSEL and photodiode (PD) arrays, aimed at addressing the increasing data traffic demands in modern datacenters [1][7] Technology Advancements - The new high-density 2D array architecture (1.6T, 850 nm, 32x50G NRZ) leverages Coherent's proven 100G PAM4 multimode VCSEL and PD platform, facilitating copper link replacement and enhancing parallelism [2] - These arrays are designed for low power consumption, reduced latency, and cost efficiency, supporting the transition to Near-Packaged Optics (NPO) and Co-Packaged Optics (CPO) for AI/ML workloads in hyperscale datacenters [2] Future Developments - Coherent plans to introduce 1060 nm backside-emitting (BSE) flip-chip VCSEL/PD array variants in 2026, expanding its product portfolio for next-generation optical networking [4] - The innovation will be showcased at ECOC 2025 in Copenhagen, Denmark, from September 29 to October 1, 2025 [4] Company Overview - Coherent is recognized as a global leader in photonics, providing technology solutions for datacenter, communications, and industrial markets [5] - Founded in 1971, the company operates in over 20 countries and offers a comprehensive technology stack and supply chain resilience to address complex technology challenges [6]

WhaleTales adds regulatory and political coverage, mainstream crypto news, and market analysis to Aether’s multi-asset financial media portfolio New York, NY, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Alpha Edge Media, Inc., a wholly owned subsidiary of Aether Holdings, Inc. (NASDAQ: ATHR), today announced the acquisition of WhaleTales, an online cryptocurrency-focused newsletter published on the beehiiv platform. Alpha Edge Media is a digital-first financial media company that builds, acquires, and scales newslet ...

Sales launch marks pivotal commercial milestone, unlocking up to $30 million in potential revenue through 2028GAITHERSBURG, Md., Sept. 25, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its collaboration with Sygnature Discovery, a leading contract resear ...

除美国外，SuperX近期在日本、中国等市场都展开了紧锣密鼓的布局动作。 7月28日，SuperX宣布旗下子公司SuperX Industries Pte.Ltd.计划在日本建立其首个区域人工智能供应中 心，该中心预计2025年下半年投产，全面投入运营后，将具备每年为1万台SuperX自有品牌高性能AI服 务器进行最终组装、系统集成与严格品控的交付能力。AI供应中心将专注于公司品牌核心产品(包括高 性能人工智能服务器、高压直流(HVDC)电源系统和高密度液体冷却解决方案)的最终组装、系统集成和 质量控制，能够为日本及亚洲客户提供更快速、更贴近本地需求的交付体验。 7月30日，SuperX正式发布最新旗舰产品SuperX XN9160-B200AI服务器。该服务器搭载NVIDIA最新一 代Blackwell架构GPU(B200)，旨在满足客户对人工智能(AI)、机器学习(ML)和高性能计算(HPC)应用程 序的高性能和可扩展性的算力需求。 9月15日，SuperX子公司牵手中国数字能源企业中恒电气（002364）设立合资公司SuperX Digital Power Pte.Ltd，双方将整合在客户资源、技术储备 ...

Accessibility StatementSkip Navigation The new ONE1600ER module combined with enhancements to the MAP-300 portfolio help customers meet AI- driven demands CHANDLER, Ariz., Sept. 25, 2025 /PRNewswire/ --Â VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) has expanded the functionality of its award-winning ONE LabPro testing and validation platform. Following the launches of the ONE-1600 and second generation ONE-1600IE solutions, the new ONE-1600ER module delivers enhanced features and enables comprehensive testin ...

That's a wrap!If you found it insightful, reshare it with your network.Find me → @_avichawlaEvery day, I share tutorials and insights on DS, ML, LLMs, and RAGs. ...

Company Overview - Intermap Technologies Corporation is a global leader in 3D geospatial products and intelligence solutions, focusing on the creation and analysis of 3D terrain data to produce high-resolution thematic models [11] - The company utilizes scientific analysis of geospatial information and patented sensors and processing technology to provide diverse, multi-source datasets for seamless integration into customer workflows [11] Offering Details - Intermap has filed a prospectus supplement for a bought deal public offering of 8,334,000 Class A common shares at a price of $3.00 per share, aiming for aggregate gross proceeds of $25,002,000 [1][2] - The offering is underwritten by a syndicate led by Stifel Nicolaus Canada Inc., including Canaccord Genuity Corp. and Beacon Securities Limited [3] - An over-allotment option allows underwriters to purchase an additional 1,250,100 common shares, potentially increasing total gross proceeds to $28,752,300 if fully exercised [4] Use of Proceeds - The net proceeds from the offering are intended for working capital and general corporate purposes, as detailed in the prospectus supplement [5] Regulatory Compliance - The prospectus supplement has been filed in each province of Canada (excluding Québec) and is qualified for distribution in the United States on a private placement basis to "Qualified Institutional Buyers" [2]

I think it's fair to say that we really are at an inflection point right now. We're make ... We're clearly in a ... making a transition. So, you know, pre-2007, we had feature phones, between 2007 and now, ish, right, we've had smartphones, and in the last few years, clearly we're making a transition into a new category, and that's an AI phone. And I feel that Pixel and Tensor have really been at the front of that pack. We made that turn into that inflection point early. Welcome to the Made by Google podcas ...

Key Takeaways The Fed's 25 bps rate cut and projections for more create a favorable backdrop for fintech growth.CSGP, PYPL, SOFI, IBKR and HOOD are highlighted as top investment picks.All five companies show strong revenue and earnings growth expectations for the current year.On Sept. 17, the Fed in its FOMC meeting decided on a much-hyped 25-basis-point cut in the benchmark lending rate to reduce it to the range of 4-4.25%. This is the first interest rate cut of this year. Moreover, the Fed’s dot-plot has ...

Eli Lilly has revealed it is to build an active pharmaceutical product (API) facility in Texas, US, a week after revealing Virginia as the first site in its $27bn US manufacturing drive. The $6.5bn manufacturing facility will produce Eli Lilly’s array of small molecule therapeutics – chief among which will be orforglipron, the drugmaker’s oral glucagon-like peptide-1 receptor agonist (GLP-1RA) hopeful in obesity treatment. Lilly’s CEO David Ricks said: "Our new Houston site will enhance Lilly's ability t ...